WIRED's Robbie Gonzalez learned to solve a Rubik's cube from Tyson Mao, one of the co-founders of the World Cube Association. In two weeks, Robbie got his solve time down from 45 minutes with Tyson, ...

With as many problems as we are all faced with in our work and life, it seems as if there is never enough time to solve each one without dealing with some adversity along the way. Problems keep ...

For some people, solving a jigsaw puzzle is a relaxing activity, and their preferred way of winding down at the end of the day. For others, it’s a race to the finish. Sure, it’s fun to spend hours ...

In coaching others, I often discuss problem-solving strategies to help individuals think creatively and consider many options when they are faced with challenging situations. Problem solving 1-2 ...

AlphaProof and AlphaGeometry 2 are steps toward building systems that can reason, which could unlock exciting new capabilities. AI models can easily generate essays and other types of text. However, ...

Often leaders will think they are driving a problem-solving culture by insistent, or even just encouraging, team members to utilize the tools and templates of problem-solving. However, most ...

One of the most common (and deadly) mistakes in entrepreneurship is creating a solution before identifying the problem. You might think you have the next big idea, but have you really done the ...

Legal tech has come a long way, but the bulk of an intellectual property or patent lawyer’s work today is still done with spreadsheets, word processors, and PDFs. A startup out of Delaware, Solve ...

Five steps to ensure that you don’t jump to solutions by Julia Binder and Michael D. Watkins When business leaders confront complex problems, there’s a powerful impulse to dive right into “solving” ...

Jake Fillery is an Evergreen Editor for Game Rant who has been writing lists, guides, and reviews since 2022. With thousands of engaging articles and guides, Jake loves conversations surrounding all ...

A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...